Stocks
Immunome (IMNM) Debt/EBITDA US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| Debt/EBITDA | 0.20 | 2.30 | 2.04 | 0.55 | 4.83 | 1.98 | |||
| Changes by years, y/y, % | +243% | +1 029% | -11% | -73% | +774% | +141.1% | |||
Immunome. Debt/EBITDA
Immunome. Debt/EBITDA, changes, %
Immunome (IMNM) Debt/EBITDA US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| Debt/EBITDA | 4.08 | 4.82 | 7.00 | 3.73 | 1.98 | 1.98 | ||
| Changes by years, y/y, % | +453% | +773% | +363% | +156% | -51% | |||
| Changes by quarters, q/q, % | +180% | +18% | +45% | -47% | -47% | |||
